Although obesity can lead to the development of type 2 diabetes mellitus, dyslipidemia, as well as arterial hypertension [8], obesity alone, even in the absence of these metabolic disorders, can increase the risk for heart failure and ASCVD [9]
Slowing the rate by eating more, not by reducing medication, is usually the better approach
Um, Marissa Liza: and then of course, again, I'm playing devil's advocate here, right
Your provider wont simply write a prescription and have it fill without review
A network meta-analysis found that adverse events were more frequent with retatrutide (relative risk 4.10) compared to tirzepatide (relative risk 2.78)
Many patients starting semaglutide injections ask when they will notice the medication working